al., 2010, 2011) (see Figure 7). Each used the DASS-21 (Lovibond and Lovibond, 1995). Figure 7. Individual transdiagnostic CBT vs. control conditions, generic measures tCBT versus control conditions Two studies provided posttreatment Anxiety severity measures. anxiety data for group tCBT versus a control condition (Erickson et al., 2007; Schmidt et al., 2012). Erickson et al. (2007) used the BAI (Beck and Steer, 1990) while Schmidt et al. (2012) used the SPRAS (Sheehan, 1983). Results are not meta-analysed because of substantial heterogeneity (I2=80%, = 0.03). Individual effect sizes are summarized in Figure 8. p Group transdiagnostic CBT vs. control conditions, anxiety Figure 8. measures Only Schmidt et al. (2012) provided Depression severity measures. posttreatment depression-specific severity data, trial the BDI-II (Beck, Steer and Brown, 1996). The SMD was favouring tCBT (95% CI to −0.38, −0.80 0.04). Schmidt et al. (2012) alone provided Generic severity measures. posttreatment generic mental health severity data. They used the CGI (Guy, 1976). The SMD was favouring tCBT (95% CI to −0.99, −1.43 −0.55).
al., 2010, 2011) (see Figure 7). Each used the DASS-21 (Lovibond and Lovibond, 1995). Figure 7. Individual transdiagnostic CBT vs. control conditions, generic measures tCBT versus control conditions Anxiety severity measures. Two studies provided posttreatment anxiety data for group tCBT versus a control condition (Erickson et al., 2007; Schmidt et al., 2012). Erickson et al. (2007) used the BAI (Beck and Steer, 1990) while Schmidt et al. (2012) used the SPRAS (Sheehan, 1983). Results are not meta-analysed because of substantial heterogeneity (I2=80%, p = 0.03). Individual effect sizes are summarized in Figure 8. Figure 8. Group transdiagnostic CBT vs. control conditions, anxiety measures Depression severity measures. Only Schmidt et al. (2012) provided posttreatment depression-specific severity data, the BDI-II (Beck, Steer and Brown, 1996). The SMD was −0.38, favouring tCBT (95% CI −0.80 to 0.04). Generic severity measures. Schmidt et al. (2012) alone provided posttreatment generic mental health severity data. They used the CGI (Guy, 1976). The SMD was −0.99, favouring tCBT (95% CI −1.43 to −0.55). trial